Viking Therapeutics's market cap is currently $2.46B. The company's EPS TTM is €-0.49561889719999996; its P/E ratio is ―; Viking Therapeutics is scheduled to report earnings on July 24, 2025, and the estimated EPS forecast is €-0.60. See an overview of income statement, balance sheet, and cash flow financials.
